Comparison of changes in creatinine values in heart failure patients pre and post angiography in the reduced with preserved ejection fraction group
Keywords:
Angiography, HFrEF, HFpEF, CreatinineAbstract
Background and aim: Sudden changes in renal function are a common complication of coronary angiography, and percutaneous coronary intervention, especially due to contrast-induced acute kidney injury or contrast-induced nephropathy. Iodine contrast media is essential in invasive and interventional cardiac procedures. Increased use of contrast media, and an increasing number of invasive cardiac procedures performed on high-risk patients. This study aims to determine the comparison of changes in creatinine values of pre- and post-angiography patients in the HFrEF and HFpEF groups. Methods: Retrospective cohort with 85 samples of Heart Failure patients with HFrEF and HFpEF who underwent angiography. The data collection method uses secondary data, namely medical record data at the Integrated Heart Center of RSUP Dr. Wahidin Sudirohusodo. Statistical analysis used the Wilcoxon Signed Ranks Test and Mann-Whitney. Statistical test results are considered significant if the test p value is <0.05. Results: Comparison of pre and post angiography creatinine values in all study samples. There was a significant difference in mean creatinine values, namely post angiography, 1.06 + 0.45 mg/dL compared to pre angiography, namely 1.00 + 0.40 mg/dL (p<0.05). HFrEF patients were found to have significantly higher creatinine values post angiography, 0.91+0.27 mg/dL (p<0.05). There were no significant results for pre-angiography creatinine values in HFrEF and HFpEF patients and post-angiography in HFrEF and HFpEF patients (0.062). Conclusion: HFrEF patients who underwent angiography experienced an increase in creatinine values after angiography.
References
Perki KKGJ dan K. Pedoman Tatalaksana Gagal Jantung. Perhimpun Dokter Spesialis Kardiovaskular Indonesia. Published online 2020. pp.848-853.
Kapiloff MS, Emter CA. The cardiac enigma: current conundrums in heart failure research. F1000Research. 2016;5. doi: 10.12688/f1000research.7278.1
Sahle BW, Owen AJ, Mutowo MP, Krum H, Reid CM. Prevalence of heart failure in Australia: a systematic review. BMC Cardiovasc Disord. 2016:16:1-6.
Hobbs FDR, Roalfe AK, Davis RC, Davies MK, Hare R. Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES). Eur Heart J. 2007;28(9):1128-1134. doi: 10.1093/eurheartj/ehm102
Wangko LC, Budiono B, Lefrandt RL. Angiografi Koroner Indikasi, Kontraindikasi, Dan Proteksi Terhadap Radiasi. J Biomedik JBM. 2012;4(3). doi: 10.35790/jbm.4.3.2012.794
Kay P, Sabate M, Costa MA. Cardiac Catheterization and Percutaneous Interventions. CRC Press; 2004. doi: 10.3109/9780203494837
Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79(17):e263-e421. doi: 10.1161/CIR.0000000000001063
Elserafy AS, Okasha N, Hegazy T. Prevention of contrast induced nephropathy by ischemic preconditioning in patients undergoing percutaneous coronary angiography. Egypt Hear J. 2018;70(2):107-111. doi: 10.1016/j.ehj.2017.12.004
Modi K, Padala SA, Gupta M. Contrast-induced nephropathy. Published online 2017. www.ncbi.nlm.nih.gov/books/NBK448066/?report=printable
Liu C, Mor MK, Palevsky PM, et al. Postangiography increases in serum creatinine and biomarkers of injury and repair. Clin J Am Soc Nephrol. 2020;15(9):1240-1250. doi: 10.2215/CJN.15931219.
Widaningsih Y, Natsir R, Arif M, et al. Analysis of Serum Creatinine Level and Contrast Volume in Contrast Induced Nephrophaty Incidence after Percutaneus Coronary Intervention. Int J Sci Basic Appl Res. 2017;32(3):186-193. https://gssrr.org/index.php/JournalOfBasicAndApplied/article/view/7174
Stolker JM, McCullough PA, Rao S, et al. Pre-procedural glucose levels and the risk for contrast-induced acute kidney injury in patients undergoing coronary angiography. J Am Coll Cardiol. 2010;55(14):1433-1440. doi: 10.1016/j.jacc.2009.09.072
Hossain MA, Costanzo E, Cosentino J, et al. Contrast-induced nephropathy: Pathophysiology, risk factors, and prevention. Saudi J Kidney Dis Transplant. 2018;29(1):1-9. doi: 10.4103/1319-2442.225199
Chioncel O, Lainscak M, Seferovic PM, et al. Epidemiology and one‐year outcomes in patients with chronic heart failure and preserved, mid‐range and reduced ejection fraction: an analysis of the ESC Heart Failure Long‐Term Registry. Eur J Heart Fail. 2017;19(12):1574-1585. doi: 10.1002/ejhf.813
Chyrchel M, Hałubiec P, Łazarczyk A, et al. Low ejection fraction predisposes to contrast-induced nephropathy after the second step of staged coronary revascularization for acute myocardial infarction: a retrospective observational study. J Clin Med. 2020;9(6):1812. doi: 10.3390/jcm9061812
He H, Chen XR, Chen YQ, Niu TS, Liao YM. Prevalence and predictors of contrast-induced nephropathy (CIN) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI): a meta-analysis. J Interv Cardiol. 2019;2019. doi: 10.1155/2019/2750173
Silver SA, Shah PM, Chertow GM, Harel S, Wald R, Harel Z. Risk prediction models for contrast induced nephropathy: systematic review. Bmj. 2015;351. doi: 10.1136/bmj.h4395
Barzi F, Miri R, Sadeghi R, et al. A randomized double blind placebo controlled trial examining the effects of pentoxifylline on contrast induced nephropathy reduction after percutaneous coronary intervention in high risk candidates. Iran J Pharm Res. 2019;18(2):1040-1046. doi: 10.22037/ijpr.2019.12557.10977
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Fransiska Rosdiana Liling, Idar Mappangara, Haerani Rasyid, Syakib Bakri, Andi Makbul Aman, Andi Alfian Zainuddin
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
